We sought to characterize the effects of engineered beige fat on
metabolic diseases by reviewing its history, examining experimental
data, exploring putative mechanisms of action, and predicting its
therapeutic future.White adipocytes are highly adaptable and can
transform into beige adipocytes with thermogenic capacity, which have
beneficial effects in treating metabolic diseases. However, access to
beige adipocytes is limited, and treatment efficacy decreases over time.
Thus, new approaches are needed to enhance the adaptive thermogenic
capacity of beige adipocytes. The investigation revealed that engineered
techniques, such as induction of stem cell regeneration, adipocyte gene
editing, and adipocyte reprogramming techniques, can generate beige
adipose tissue via autologous cell induction, adipose tissue remodeling,
and functional biomaterials. Engrafted engineered beige adipocytes can
generate large amounts of UCP1-positive adipose tissue in patients with
metabolic diseases, paving the way for developing metabolically active
beige adipose tissue and expanding its functionality in metabolic
therapy. Understanding how engineered beige fats treat metabolic
diseases will aid in disease prevention and treatment. These
sophisticated tissue engineering systems offer new avenues for
generating functional beige adipose tissue in patients with metabolic
diseases.